因专利纠纷,德国一法院叫停默沙东Keytruda皮下注射剂上市

Minhua笔记
Dec 07, 2025

12月4日,德国慕尼黑地区法院第七民事庭裁定默沙东的Keytruda SC(皮下注射剂)侵犯Halozyme Therapeutics的欧洲专利EP 2 797 622(MDASE技术),发出初步禁令,禁止默沙东在德国销售和提供该产品。禁令仅针对Keytruda SC,不影响静脉注射剂;默沙东已于今年8月启动专利无效程序,案件待德国联邦专利法院审理。Halozyme指控Keytruda SC侵犯其...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10